| ALBERT LABS INTL. CORP. |
| Kanada |
| Gesundheit |
| CA0127841041 / A3DJEF |
| VB50 (Frankfurt) |
| FRA:VB50, ETR:VB50, VB50:GR |
| - |
| https://albertlabs.com/ |
|
Albert Labs International Corp., a biotechnology and pharmaceutical company, focuses on transforming mental health treatment through the development of innovative, psilocybin-based therapies. The company's primary objective is to create effective and..
>Volltext.. |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| ALBERT LABS |
| 05.04.26 |
|